SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

51Talk Online Education Group is a global online education platform focusing on English lessons. It operates through the following geographical segments: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia. The company was founded by Jia Jia Huang, Ting Shu, and Li Ming Zhang in July 2011 and is headquartered in Singapore.

51 Talk Online Education Group - ADR

51Talk remains a focal point for investors as the community debates whether the companys pivot to international markets and its low float create a deep-value opportunity or a liquidity trap. While shareholders point to active share buybacks from the founder and aggressive expansion as bullish indicators, persistent low trading volume and frustration over delayed financial reporting continue to fuel concerns regarding valuation transparency.

Lobstar

Investors are actively debating the momentum of Lobstar as a speculative AI-themed asset, with community members weighing the potential for continued upside against strategic profit-taking and rotation into other emerging tokens.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is generating significant momentum as investors flock to its decentralized AI infrastructure, driven by anticipation of its upcoming supply-halving event. The community is actively debating the project's long-term potential as a foundational layer for decentralized intelligence, drawing frequent comparisons to Bitcoin's scarcity model and early-stage growth trajectory.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased community debate as traders weigh the impact of recent workforce reductions and structural shifts against high network transaction volume and ongoing institutional partnerships. While some investors remain cautious due to extended price volatility and market sentiment, others highlight the project's recent regulatory clarity as a digital commodity as a key development for its long-term positioning.

Clear Secure, Inc. is a secure identity company, which engages in developing biometric identity verification technology platforms. Its identity platform connects passengers to the cards in their wallet transforming the way passengers live, work, and travel, and focuses on providing verification in several areas, such as events, healthcare, and sporting stadiums. The company was founded by Caryn Seidman-Becker and Kenneth Cornick in 2010 and is headquartered in New York, NY.

Clear Secure Inc - Ordinary Shares Class A

Clear Secure Inc. is seeing significant investor interest driven by strong earnings, share repurchases, and its expanding role in identity verification beyond airports, including a new contract with CMS for medicare.gov. The community is actively discussing its potential as a long-term biometric infrastructure play and tracking signs of a possible short squeeze due to high short interest and institutional accumulation.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is capturing investor attention as the community eagerly anticipates upcoming smart contract mainnet launches and potential Tier-1 exchange listings. While some participants are actively accumulating and highlighting the network's scalability, others are expressing frustration over price stagnation and the challenges of trading the token on major platforms.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is facing significant market volatility following a disappointing Q4 revenue miss and soft forward guidance, despite reporting record rider growth and a new $1 billion share repurchase program. Investors are actively debating whether this selloff represents an attractive entry point into a company pivoting toward autonomous vehicle partnerships or if structural competition and margin pressures justify the downward trend.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant community-driven momentum ahead of the upcoming sentencing of co-founder Do Kwon, fueling speculation about potential project developments and market volatility. Supporters are actively discussing strategies like staking and token burns to tighten supply, while the community remains divided between those betting on a long-term turnaround and skeptics wary of the project's turbulent history.

Invesco Exchange-Traded Fund Trust II - Invesco Solar ETF

Invesco Solar ETF

Invesco Solar ETF (TAN) is trending as investors weigh conflicting catalysts, including strong earnings reports from sector leaders like Nextracker and First Solar against heightened uncertainty surrounding the upcoming U.S. election and potential changes to renewable energy subsidies. Community discussions are split between those betting on long-term secular demand for clean energy in AI-driven data centers and those wary of significant short-term volatility depending on the administration's stance on energy policy.

Nabors Industries Ltd. engages in the provision of off shore platform rigs. It also provides performance tools, directional drilling services, tubular running services, and technologies for its own rig fleet and those operated by third parties. It manufactures drilling equipment and drilling rig instrumentation. It operates through the following business segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The U.S. Drilling segment includes land drilling activities in the lower states and Alaska, as well as offshore operations in the Gulf of Mexico The International Drilling segment focuses on maintaining a footprint in the oil and gas market, most notably in Saudi Arabia, Algeria, Argentina, Colombia, Kazakhstan, and Venezuela. The Drilling Solutions segment offers drilling technologies, such as proprietary drilling-bit steering systems and rig instrumentation software. The Rig Technologies segment refers to the Canrig, which manufactures and sells top drives, catwalks, wrenches, draw works, and drilling related equipment, such as robotic systems and downhole tools. The company was founded by Clair Nabors in 1952 and is headquartered in Hamilton, Bermuda.

Nabors Industries Ltd

Nabors Industries is currently drawing significant community attention as investors debate its role as a potential value turnaround play or a struggling asset burdened by debt and sector volatility. Discussions are heavily focused on the company's recent debt reduction efforts, the potential of its Quaise Energy geothermal partnership, and frustration regarding its performance relative to broader energy sector trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Satellos Bioscience (NASDAQ:MSLE) Downgraded to "Strong Sell" Rating by Wall Street Zen

Wall Street Zen downgraded Satellos Bioscience to a "strong sell" rating in a research note on Saturday...

Satellos Bioscience (NASDAQ:MSLE) Now Covered by Cantor Fitzgerald

Cantor Fitzgerald assumed coverage on shares of Satellos Bioscience in a report on Wednesday. They set an "overweight" rating on the stock...

Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...

Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy

Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...

Satellos to Participate in Upcoming Investor Conferences

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (Satellos or the Company), a clinical-stage biotechnology company focused on restoring natural muscle repair and regeneration in degenerative muscle...

<ul class="summary-bullets"><li>MSLE stock&nbsp;was down about 2%&nbsp;in overnight trading heading into Tuesday.</li><li>The company completed a $57.2 million public offering to fund its lead drug, SAT-3247, and other research into muscle diseases.</li><li>Early data for SAT-3247 is expected in the second quarter of 2026, following encouraging adult safety results.</li></ul>Shares of Satellos Bioscience Inc. (MSLE) opened more than 10% above their offering price in the company’s Nasdaq debut on Monday before ending the session more than 3% lower and dipping over 8% in after-hours trading.Investor sentiment took a hit after the company revealed it had completed an equity raise to fund its Duchenne muscular dystrophy (DMD) program and broader muscle disease research.&nbsp;<h2 class="st-heading-2">MSLE Wraps Up Equity Raise</h2>Satellos said it has completed its underwritten public offering, raising about $57.2 million before fees. The deal included roughly 5.2 million common shares, along with pre-funded warrants for some investors. The <a href="https://stocktwits.com/symbol/MSLE">shares of Satellos</a> were sold at $10.1 each. The stock is also listed on the Toronto Stock Exchange under the MSCL ticker.The company said the funds will mainly support research and development, with a focus on advancing SAT-3247, its lead drug candidate, into mid and late-stage clinical trials. Some of the money will also be used to explore additional muscle-related diseases and support early-stage research programs.Ahead of the Nasdaq listing, Satellos carried out a 1-for-12 share consolidation in late January. This reduced the total number of shares from about 185.5 million to roughly 15.5 million, helping the stock meet Nasdaq’s listing requirements.<h2 class="st-heading-2">How SAT-3247 Works</h2>SAT-3247 is an oral drug designed to help the body repair and regenerate muscle by targeting a protein called AAK1, which plays a role in muscle stem cell signaling. Unlike gene therapies, SAT-3247 does not depend on fixing the dystrophin gene, meaning it could potentially work for a wide range of Duchenne patients, regardless of their specific genetic mutation.In December, Satellos received FDA clearance and approvals from global regulators to begin a Phase 2 clinical study of SAT-3247 in 51 children with Duchenne. The study will test safety and measure changes in muscle strength and function. The company expects early trial results in the second quarter of 2026. Earlier studies in adults showed that the drug was well tolerated and associated with improvements in grip strength over a 28-day treatment period.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for Satellos Bioscience was ‘neutral’ amid ‘extremely low’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/msle_ss_png_8d0bdc8b59.webp" alt="msle ss.png" width="973" height="142"><figcaption>MSLE sentiment and message volume as of February 10 | Source: Stocktwits</figcaption></figure>One user said the company’s “Clinical results should be pretty stellar.”<stembedurl>https://stocktwits.com/bruceleeboy/message/644522213</stembedurl>Another user said, “It looks like all went well with the listing. Great work. Let’s see if we&nbsp; get something going this Spring.”<stembedurl>https://stocktwits.com/PennyScam/message/644421647</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Satellos Bioscience Inc. (MSLE) opened more than 10% above their offering price in the company’s Nasdaq debut on Monday. (Photo credit: Getty Images)

Why MSLE Stock Gave Up All Nasdaq Debut Gains And Fell 8% After Hours

SAT-3247, an oral therapy aimed at restoring muscle repair, is now in Phase 2 testing in children with DMD.

Equity

Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters Option to Purchase Additional Shares

Satellos Announces Pricing of US$50 Million Public Offering in Canada and the United States

Satellos Bioscience Inc. (TSX: MSCL, Nasdaq: MSLE) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.

Current Price	$7.24
Prev Close	$8.01
Open	$7.81
Dividend Yield	0.00%
50-Day Moving Average	$10.20
Beta	0.09
Avg. Volume	56,786.95
PE Ratio	-4.61

52-Week High	$13.39
52-Week Low	$4.53
Market Capitalization	$111.92M
EPS (Annual)	-$2.14
Price to Book	3.28
Revenue Per Employee	$0.00

MSLE
Satellos Bioscience Inc

Feed

News

Sentiment

Fundamentals

Info

Latest MSLE News

MSLESatellos Bioscience Inc